« Zurück
Startseite /
Human ST3GAL4 Protein (ST3-HM1L4HA)

Human ST3GAL4 Protein (ST3-HM1L4HA)

ArtNr	ST3-HM1L4HA-100UG
Hersteller	KactusBio
Menge	100 ug
Quantity options	100 ug 500 ug
Kategorie	Metabolism Diabetes Peptides & Proteins Recombinant Proteins
Typ	Proteins Recombinant
Format	Lyophilized
Specific against	Human (Homo sapiens)
Host	HEK293
Konjugat/Tag	HIS, HA
Purity	> 95% as determined by Bis-Tris PAGE
Formula	Supplied as 0.22μm filtered solution in 20mM Tris, 500mM NaCl (pH 7.5).
Sequence	Glu41-Phe333
NCBI	Q11206.1
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	SIAT4,SIAT4C, ST3GAL4,ST3GalA.2,ST-4,STZSIAT4, CGS23,Gal-NAc 6S,NANTA3,SAT3,SAT-3
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Recombinant Protein
Manufacturer - Targets	ST3GAL4
Manufacturer - Conjugate / Tag	N-HA, C-His
Shipping Temperature	Shipped at ambient temperature.
Storage Conditions	-20 to -80°C for 12 months as supplied from date of receipt.；-80°C for 3 months after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Molecular Weight	The protein has a predicted MW of 35.4 kDa. Due to glycosylation, the protein migrates to 48-53 kDa based on Bis-Tris PAGE result.
Description	Recombinant Human ST3GAL4 Protein is expressed from HEK293 with His tag at the C-Terminus and HA at the N-Terminus.It contains Glu41-Phe333.
Background	ST3GAL4 gene expression is altered in different cancer types, including cervical cancer. Several mRNA transcripts have been reported for this gene. ST3GAL4 encodes for β‑galactosidase α‑2, 3‑sialyltransferase 4, involved in the biosynthesis of the tumour antigens sLe(x) and sulfo‑sLe(x).
Endotoxin	Less than 1 EU per μg by the LAL method.
Formulation	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution	Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 μg or less, at 1mg/ml for 500μg or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Biotinylated	no

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

ST3-HM1L4HA-100UG-datasheet.pdf

ST3-HM1L4HA-100UG-safety-datasheet.pdf